ArticleCureus2021

Increased Risk of Second Primary Malignancy and Mortality at ten Years After Stem Cell Transplant for Multiple Myeloma: An Analysis of 14,532 Patients.

Brittany Miles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.